NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT01397305 2020-09-09An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerIsofol Medical ABPhase 1/2 Completed24 enrolled
NCT00377520 2009-11-20A Trial for Patients With Advanced/Recurrent Endometrial CancerEli Lilly and CompanyPhase 2 Completed27 enrolled 10 charts